Glossary

The process of determining the best dose for achieving desired effects with minimal side effects.

The process of monitoring and managing a clinical trial to ensure compliance and participant safety.

The oversight of a clinical trial to ensure protocol compliance and participant safety.

A document outlining how data will be collected, stored, and analyzed during a clinical trial.

The final phase of a clinical trial, including data analysis and regulatory reporting.

A trial design where participants receive multiple interventions in a specific sequence.

Methods used to encourage participants to stay in a clinical trial until its completion.

Support provided to patients to ensure their rights and needs are prioritized in clinical trials.

The process of identifying and enrolling eligible participants for a clinical trial.

A laboratory analyzing clinical trial samples from multiple sites.

Ending a clinical trial early due to safety, efficacy, or operational concerns.

Participation in a trial by free choice, without coercion or undue influence.

When a participant leaves or is removed from a clinical trial before its completion.

A request to the FDA for authorization to test a drug in humans.